logo-loader

PreveCeutical develops proprietary method for extracting cannabinoids for Sol-gel

Last updated: 22:28 21 Sep 2018 BST, First published: 12:00 24 Sep 2018 BST

PreveCeutical Medical Inc. (CSE:PREV) CEO and President Stephen Van Deventer joined Steve Darling in the Vancouver studio of Proactive Investors to talk about the companies recent news that they had successfully optimized the conditions for extracting cannabinoids from one of its cannabis strains and developed a proprietary method for the accurate measurement of cannabinoids.

Van Deventer also shared details of their duel gene therapy program that deals with diabetes and obesity.
 

Arrow Exploration CEO on Icaco success, record production and next drilling...

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott talked with Proactive's Stephen Gunnion about the company's latest drilling success at Icaco in Colombia, where the IC-HZ9 well has exceeded production expectations and helped lift corporate output above 7,000 barrels of...

4 hours, 37 minutes ago